Status:
COMPLETED
Intravitreous CytokinE Level in pAtient With retiNal Detachment
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Retinal Detachment
Eligibility:
All Genders
18+ years
Brief Summary
Photoreceptor apoptosis is the basis for permanent visual loss in a number of retinal disorders including age-related macular degeneration (AMD) and retinal detachment (RD). Thus, despite tremendous a...
Eligibility Criteria
Inclusion
- Patients with primary retinal detachment requiring vitrectomy
- Patients with idiopathic macular hole requiring vitrectomy
Exclusion
- History of retinal detachment or intraocular inflammatory diseases
Key Trial Info
Start Date :
November 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 11 2018
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT03318588
Start Date
November 15 2017
End Date
October 11 2018
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brabois Hospital
Vandœuvre-lès-Nancy, France, 54500